Latest Market Expansion News

StepChange Holdings has reported robust organic growth with a 19% revenue increase in its first half as an ASX-listed company, complemented by a strategic acquisition expanding its government sector presence.

Eden Innovations has appointed Dr Allan Godsk Larsen as Managing Director to spearhead its global growth, leveraging his deep expertise in carbon nanotube technology amid strong commercial momentum and significant debt reduction.

X2M Connect Limited reported a robust first half of FY26 with a 45% revenue increase and significant contract wins in Asia, positioning the company for sustained growth.

CAR Group Limited has reported a strong first half for FY26, posting 13% revenue growth and reaffirming its optimistic outlook for the full year, driven by strategic AI integration and global market expansion.

CAR Group Limited reported a strong half-year result for the period ending 31 December 2025, with revenue up 8% and adjusted net profit rising 11.5%, driven by robust performance across Australia, North America, Latin America, and Asia.

A single exploration name blew the doors off the leaderboard, while two well-known uranium plays and a Nevada explorer sank hard. Behind the noise: deals got closer to completion, big raisings reset prices, and several “good news” gaps didn’t survive the week.

FirstWave has unveiled a strategic shift towards AI-powered compliance management, backed by strong user growth for its Open-AudIT platform and significant cost savings from restructuring.

Epsilon Healthcare’s subsidiary, Epsilon Pharma, has signed a three-year manufacturing agreement with New Zealand’s Puro to supply medicinal cannabis products to the UK and Europe, marking a significant step in its international expansion.

Vmoto Limited reports a robust sales rebound in the final quarter of 2025, with a 68% jump in units sold and a near doubling of firm orders, underpinned by strategic partnerships and expanding manufacturing capacity.

Vitrafy Life Sciences has delivered key milestones in the first half of FY26, including a strategic partnership with IMV Technologies and progress in clinical studies, while maintaining a strong cash position to support its U.S. expansion and product launches.

OncoSil Medical secures $8 million in capital to fund a pivotal German government-sponsored clinical trial and accelerate its European commercial expansion.

Aroa Biosurgery’s latest business update reveals promising clinical outcomes from its Myriad trauma study and evolving reimbursement policies that could reshape its market position. The company also projects solid revenue growth for FY26, supported by strategic commercial initiatives.